Department of Neurology, Toho University Omori Medical Center, 6-11-1 Omorinishi, Otaku, Tokyo 143-8541, Japan.
Parkinsons Dis. 2011;2011:143547. doi: 10.4061/2011/143547. Epub 2011 May 12.
Depression and anxiety are common in Parkinson's disease (PD) and have important consequences on quality of life. These have long been recognized as frequent accompanying syndromes of PD, and several reports suggest that these are the causative process or risk factors that are present many years before the appearance of motor symptoms. The neurochemical changes in PD involving dopamine, norepinephrine, and serotonin might be related to the pathophysiology of depression and anxiety, but this is still not clear. Several studies showed that anxiety in PD patients occurs earlier than depression, during premotor phase, suggesting that there may be a link between the mechanisms that cause anxiety and PD. Whereas a recent study reported that PD patients with depression and anxiety were associated with different demographic and clinical features.
抑郁和焦虑在帕金森病(PD)中很常见,对生活质量有重要影响。这些问题长期以来一直被认为是 PD 的常见伴随综合征,有几项报告表明,这些问题是在运动症状出现多年前就存在的致病过程或危险因素。PD 中涉及多巴胺、去甲肾上腺素和 5-羟色胺的神经化学变化可能与抑郁和焦虑的病理生理学有关,但这仍不清楚。几项研究表明,PD 患者的焦虑发生在运动前期早于抑郁,这表明导致焦虑和 PD 的机制之间可能存在联系。而最近的一项研究报告称,伴有抑郁和焦虑的 PD 患者具有不同的人口统计学和临床特征。